Successful treatment discontinuation in CML patients with full-dose and low-dose TKI: Results from real-world practice

• Main Authors: Yilin Chen (Author), Huifang Zhao (Author), Jingming Guo (Author), Jing Zou (Author), Wenjuan He (Author), Danlei Han (Author), Fanjun Cheng (Author), Yanli Zhang (Author), Weiming Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: In clinical studies, some patients who achieve deep molecular response (DMR) can successfully discontinue tyrosine kinase inhibitor (TKI). TKI dose reduction is also an important aspect of alleviating adverse effects and improving quality of life. This study aimed to explore the outcome...